EVOX THERAPEUTICS LIMITED
Research and experimental development on biotechnology
EVOX THERAPEUTICS LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Full company profile for EVOX THERAPEUTICS LIMITED (10076821), an active life sciences and medical technology company based in United Kingdom. Incorporated 22 Mar 2016. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2016–2024)
Cash in Bank
£21.44M
Net Assets
£26.18M
Total Liabilities
£2.19M
Turnover
N/A
Employees
58
Debt Ratio
8%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
See all 4 funding rounds
Sign up to view complete fundraising history
Investors (11)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 7 | May 2016 | Series B, Series A, Series C |
| Investor 2 | Sept 2018 | Series B, Series C |
| Investor 3 | Sept 2018 | Series B, Series C |
See all 11 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Alex Eric Hammacher | Director | British | United Kingdom | 21 Sept 2023 | Active |
| Gordon Wild, Sarah Lucinda | Director | British | England | 15 Mar 2017 | Active |
See all 18 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Oxford Science Enterprises Plc
United Kingdom
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
| Address | Tenure | Price Paid | Date Added |
|---|---|---|---|
Medawar Centre Building 2, Robert Robinson Avenue, Oxford (OX4 4HG) OXFORD | Leasehold | - | 12 Nov 2021 |
Medawar Centre (Building 2), Oxford Science Park, Robert Robinson Avenue, Oxford (OX4 4GA) OXFORD | Leasehold | - | 6 Feb 2019 |
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 18 Apr 2026 | Accounts | Annual accounts made up to 2025-12-31 | |
| 30 Mar 2026 | Confirmation Statement | Confirmation statement made on 2026-03-16 with updates | |
| 9 Jan 2026 | Officers | Appointment of Douglas Treco as director on 2025-10-20 | |
| 6 Oct 2025 | Officers | Appointment of Wallace Wallace as director on 2025-09-12 | |
| 6 Oct 2025 | Officers | Termination of Alex Eric Hammacher as director on 2025-09-09 |
Annual accounts made up to 2025-12-31
Confirmation statement made on 2026-03-16 with updates
Appointment of Douglas Treco as director on 2025-10-20
Appointment of Wallace Wallace as director on 2025-09-12
Termination of Alex Eric Hammacher as director on 2025-09-09
Recent Activity
Latest Activity
Annual accounts made up to 2025-12-31
1 days ago on 18 Apr 2026
Confirmation statement made on 2026-03-16 with updates
2 weeks ago on 30 Mar 2026
Appointment of Douglas Treco as director on 2025-10-20
3 months ago on 9 Jan 2026
Appointment of Wallace Wallace as director on 2025-09-12
6 months ago on 6 Oct 2025
Termination of Alex Eric Hammacher as director on 2025-09-09
6 months ago on 6 Oct 2025